Who is sponsoring NCT05766618?

NCT05766618 is sponsored by Cairo University.

What condition does NCT05766618 study?

NCT05766618 studies Platelet-Rich Fibrin, Acceleration, Orthodontics.

Is NCT05766618 still recruiting?

NCT05766618 is currently status unknown. Last updated 13 March 2023.

Last reviewed 2023-03-13 · How we verify

NCT05766618

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Multiple Injections of (PRF) on The Rate of Canine Retraction

Status unknown Phase 3 Last updated 13 March 2023

What this trial tests

Phase 3 trial testing Injectable platelet rich fibrin (i-PRF): in acceleration of orthodontic tooth movement in Platelet-Rich Fibrin in 22 participants. Status unknown.

Timeline

1 April 2023

Primary endpoint
1 June 2024

1 October 2024

Quick facts

Lead sponsor	Cairo University
Phase	Phase 3
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	22
Start date	1 April 2023
Primary completion	1 June 2024
Estimated completion	1 October 2024
Sites	1 location across Egypt

Drugs / interventions tested

Injectable platelet rich fibrin (i-PRF): in acceleration of orthodontic tooth movement

Conditions studied

Platelet-Rich Fibrin — all drugs for Platelet-Rich Fibrin →
Acceleration — all drugs for Acceleration →
Orthodontics — all drugs for Orthodontics →

Sponsor

Cairo University

Who can join

Adults 16 to 24, any sex, with Platelet-Rich Fibrin or Acceleration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

this clinical trial aims to prove that multiple injections will produce a steady rate of acceleration of orthodontic tooth movement.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Platelet-Rich Fibrin

Currently open trials in the same condition.

NCT06679283 — Surgical Treatment of Peri-implantitis With Adjunctive Application of Platelet Rich Fibrin (PRF) · NA · recruiting

Other Cairo University trials

Trials by the same sponsor.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07363239 — CBCT-Based Safety Distance for Implant Placement Near the Inferior Alveolar Canal · not yet recruiting
NCT07374575 — Egyptian Dental Professionals' Perspectives on the Oral Microbiome and Exosomes · not yet recruiting
NCT07381153 — In-Vitro Cytotoxicity Assessment of INOX (Nanoksa G Plus) Polymer Discs · not yet recruiting
NCT07375394 — 3D-Printed Extraoral Camera for Standardized Dental Photography · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05766618 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cairo University
Last refreshed: 13 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05766618.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing